Published in Br J Obstet Gynaecol on December 01, 1976
Aetiology of pre-eclampsia: a review. J R Soc Med (1980) 0.79
The fibrinolytic system in pre-eclampsia. J Clin Pathol (1984) 0.77
Blood clotting and fibrinolysis in pregnancy. Postgrad Med J (1979) 0.75
Analysis of ethnic differences in perinatal statistics. Br Med J (1980) 6.15
Ethnic differences in the distribution of congenital malformations. Postgrad Med J (1983) 3.17
The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med (1969) 2.39
Attitudes of patients to clinical teaching. Br J Med Educ (1967) 2.28
Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest (1969) 2.14
Ethnic differences in congenital malformations. Arch Dis Child (1985) 1.75
Postgraduate medical degrees of the University of Aberdeen, 1931-69. Scott Med J (1970) 1.64
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol (1966) 1.55
Venous thrombosis following strokes. Lancet (1972) 1.46
Familial thrombosis: inherited deficiency of antithrombin III. Br Med J (1978) 1.40
Studies on the blood fibrinolytic enzyme system following acute myocardial infarction. Clin Sci (1967) 1.26
Ethnic differences in incidence of very low birthweight and neonatal deaths among normally formed infants. Arch Dis Child (1987) 1.21
Further medical education of Aberdeen graduates 1956-58. Br J Med Educ (1969) 1.18
Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. Br Med J (1976) 1.15
The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor). Br J Haematol (1971) 1.12
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet (1973) 1.11
Serum Mucoproteins and Plasma Fibrinolytic Activity in Coronary-artery Disease. Br Med J (1962) 1.10
The relationship between platelet aggregation and time interval after venepuncture. Thromb Diath Haemorrh (1974) 1.08
Present employment of University of Aberdeen medical graduates, 1956-58. Lancet (1969) 1.06
The inhibition of urokinase by alpha 2 -macroglobulin. Clin Sci (1973) 0.97
The plasminogen content of thrombi. Thromb Diath Haemorrh (1966) 0.96
Studies on the fibrinolytic enzyme system in obesity. J Clin Pathol (1966) 0.94
The metabolism of Plasmodium berghei, the malaria parasite of rodents. 2. An effect of mepacrine on the metabolism of glucose by the parasite separated from its host cell. Biochem J (1961) 0.93
Evaluation of diagnostic significance of certain symptoms and physical signs in anaemic patients. Br Med J (1969) 0.92
Inhibitors of the fibrinolytic enzyme system in renal disease. Clin Sci (1970) 0.92
Effect of oestriol on platelet adhesiveness and fibrinolysis in men. Lancet (1966) 0.91
Psychogenic purpura. Br Med J (1971) 0.91
Effect of exercise on platelet count, adhesion, and aggregation. Acta Haematol (1974) 0.91
Factors influencing the prognosis in myelomatosis. Postgrad Med J (1971) 0.90
High incidence of myelomatosis in North-East Scotland. Scott Med J (1973) 0.90
Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity. J Clin Pathol (1972) 0.90
Deep venous thrombosis of the legs after strokes: Part 2-Natural history. Br Med J (1976) 0.90
Chlormethiazole in the prevention of eclampsia and the reduction of perinatal mortality. J Obstet Gynaecol Br Commonw (1969) 0.88
The inhibition of tissue activator and urokinase by human plasma. Thromb Haemost (1982) 0.88
Methotrexate and the platelet count. Br J Cancer (1968) 0.88
Coagulation and fibrinolysis in thyroid disease. Acta Haematol (1978) 0.87
Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein. Br Med Bull (1978) 0.87
A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia. Br J Obstet Gynaecol (1976) 0.87
Components of the haemostatic mechanism at birth in pre-eclampsia with particular reference to fetal growth retardation. Br J Obstet Gynaecol (1976) 0.86
The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases. J Clin Pathol (1971) 0.86
The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium. Thromb Haemost (1983) 0.86
Arcus senilis and coronary artery disease. Am Heart J (1965) 0.85
Studies on an inhibitor of plasminogen activators in human platelets. Br J Haematol (1974) 0.85
The contribution of plasma protease inhibitors to antiplasmin activity in man. Clin Sci Mol Med (1976) 0.84
Blood levels of proteinase inhibitors in pre-eclampsia. Br J Obstet Gynaecol (1983) 0.83
Inhibitors of plasminogen activation in human blood. Br J Haematol (1976) 0.83
Blood levels of proteinase inhibitors in pregnancy. Br J Obstet Gynaecol (1982) 0.83
Changes in protease inhibitors after acute myocardial infarction. J Clin Pathol (1976) 0.82
The action of antithrombin III on plasmin and activators of plasminogen. Biochim Biophys Acta (1975) 0.82
Arterio-venous differences in the components of the fibrinolytic enzyme system. Thromb Diath Haemorrh (1966) 0.81
The effect of age on the fibrinolytic enzyme system. J Clin Pathol (1974) 0.80
C1 inactivator level in pregnancy. Thromb Res (1982) 0.80
The influence of alpha-1-antitrypsin on plasmin, urokinase and Hageman factor cofactor. Biochim Biophys Acta (1974) 0.80
The influence of the platelet count on the incidence of thrombotic and haemorrhagic complications in polycythaemia vera. Postgrad Med J (1970) 0.80
Properties of a partially purified preparation of a circulating plasminogen activator. Thromb Res (1976) 0.79
Urokinase in iliofemoral venous thrombosis. Br J Surg (1969) 0.79
The fibrinolytic system in pre-eclampsia. J Clin Pathol (1984) 0.77
The effect of age upon the coagulation system. J Clin Pathol (1974) 0.77
Platelet adhesiveness and fibrinolysis after recent cerebro-vascular accidents and their relationship with subsequent deep venous thrombosis of the legs. Thromb Haemost (1976) 0.77
The influence of the polyphenols of cider on plasmin and plasminogen activators. Br J Haematol (1985) 0.76
The effeCt of vitamin c supplements on serum cholesterol, coagulation, fibrinolysis and platelet adhesiveness. Atherosclerosis (1975) 0.76
Changes in coagulation factors following acute myocardial infarction in man. Haemostasis (1976) 0.76
The effect of prolonged exercise on the components of the blood fibrinolytic enzyme system. J Physiol (1968) 0.76
An evaluation of the diagnostic significance of some symptoms and physical signs in chronic iron-deficiency anaemia. Proc Nutr Soc (1969) 0.76
Origin and employment of the medical graduates of the University of Aberdeen 1931-69. Br Med J (1970) 0.75
Effect of local exercise and vessel occlusion on fibrinolytic activity. J Clin Pathol (1977) 0.75
Thrombocytosis following thrombocytopenia in man. Postgrad Med J (1969) 0.75
Biochemistry of the plasmin system. J Clin Pathol Suppl (R Coll Pathol) (1980) 0.75
The fibrinolytic enzyme system in hypertension. J Clin Pathol (1973) 0.75
Ethnic differences in birthweight-related parameters with particular reference to possible maternal nutritional risk factors. Postgrad Med J (1983) 0.75
Fibrinolytic capacity of arm and leg veins after femoral shaft fracture and acute myocardial infarction. Br Med J (1975) 0.75
Ethnic differences in the distribution of normally formed singleton stillbirths. Postgrad Med J (1983) 0.75
Fibrinolysis in leukaemia. J Clin Pathol (1968) 0.75
Successful use of Sengstaken-Blakemore tube to control massive postpartum haemorrhage. Br J Obstet Gynaecol (1994) 0.75
Fibrinolytic activity in malignant disease. J Clin Pathol (1975) 0.75
Proceedings: The contribution of individual protease inhibitors to plasma antiplasmin activity. Thromb Diath Haemorrh (1975) 0.75
Clinical physiology of the fibrinolytic enzyme system. J Clin Pathol (1972) 0.75
Relationships between the haemostatic, complement and kinin-forming systems. Br J Haematol (1973) 0.75
Coagulant activity of the scorpion venoms Palamneus gravimanus and Leiurus quinquestriatus. Toxicon (1974) 0.75
The fibrinolytic enzyme system in leukaemia, myelomatosis and myeloproliferative diseases. Acta Haematol (1972) 0.75
The influence of haemoglobin on the fibrinolytic enzyme system. Scand J Haematol (1973) 0.75
Studies on the blood fibrinolytic system in congestive cardiac failure. Clin Sci (1973) 0.75
The fibrinolytic enzyme system in malignant lymphomas. Acta Haematol (1973) 0.75
Paralysis of the legs and venous thromboembolism. Am Heart J (1973) 0.75
Factors influencing the lysis of artificial thrombi by urokinase. Scand J Haematol (1967) 0.75
Further purification and properties of Hageman factor cofactor. Biochim Biophys Acta (1972) 0.75
The influence of personality on student reactions to clinical experience. J Med Educ (1972) 0.75
Pernicious anaemia. Nurs Times (1975) 0.75
An evaluation of gastrils: a gum-acacia based antacid. Br J Clin Pract (1968) 0.75
Inhibition of the activated Cls subunit of the first component of complement by antithrombin III in the presence of heparin. Thromb Res (1976) 0.75
Proceedings: Studies on circulating plasminogen activator. Thromb Diath Haemorrh (1975) 0.75
Platelet function after the administration of chlorpromazine to human subjects. Haemostasis (1976) 0.75
The effect of chlorpromazine and antihistamines on human blood platelets in vitro and in vivo. Bibl Anat (1973) 0.75
The effect of age on the diagnostic value of greying of the hair in addisonian pernicious anaemia. Gerontol Clin (Basel) (1972) 0.75
The fibrinolytic enzyme system in anorexia nervosa. Acta Haematol (1976) 0.75
Interrelations between ABO blood group, plasminogen, alpha1-antitrypsin, alpha2-macroglobulin and the platelet count in blood donors. Acta Haematol (1976) 0.75
The effect of clofibrate on components of the fibrinolytic enzyme system. Atherosclerosis (1973) 0.75
Properties of plasma plasminogen activators [proceedings]. J Physiol (1978) 0.75
Effect of low-density lipoprotein preparations on plasmin. Clin Sci (1973) 0.75
Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects. Drugs (1971) 0.75